Euromedica S.A., further to its announcement issued on 18 October 2007, would like to hereby inform its shareholders and investors that it has proceeded in the buyout of 49% of the shares of "IONIA PRIVATE MULTI-MEDICAL FACILITY IATRIKI S.A.", which operates a diagnostic laboratory (imaging, bio-pathology, etc.) in Elefsina, the cost of which amounted to 4,295,000 Euros. "IONIA PRIVATE MULTI-MEDICAL FACILITY IATRIKI S.A." also holds the controlling interest in "IATRIKI MEGARON PRIVATE DIAGNOSTIC LABORATORY S.A.", which operates a Diagnostic Laboratory (imaging, bio-pathology, etc.) in Megara. Euromedica S.A. has, concurrently, proceeded in the buyout of 49% of "IONIA NEPHROLOGY S.A.', the cost of which amounted to 204,000 Euros, and in the acquisition of a real estate of an area of 772 square metres in Magoula, Attiki, the cost of which amounted to 100,000 Euros, which will be used to serve the needs of this company for the operation of a Chronic Haemodialysis Unit with a capacity of 30 patients, for which the relative feasibility approval has been received. The Chronic Haemodialysis Unit is expected to begin operating in 2009.
With the aforementioned buyouts Euromedica S.A. has increased its pan-Hellenic network of primary health care facilities to 34 centres. Of these 34 centres, Euromedica S.A. operates 16 in the Attiki basin (two of which will begin operating in the near future), 5 in Thessaloniki, plus the EUROGENETIKA laboratory, 2 in Crete, 3 in Volos and 1 in Larisa, Ptolemaida, Kozani, Serres, Alexandroupoli, Trikala and Corinth.